SCHEMBL7612337

SCHEMBL7612337

CCc1cccc(C)c1CNc1cccc2[nH]c(C)nc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.53
CYP2C9 P11712 4/20 0.53
CYP2D6 P10635 4/20 0.53
CYP1A2 P05177 3/20 0.53
CYP2C19 P33261 3/20 0.53
PARP1 P09874 2/20 0.43
TRPV1 Q8NER1 1/20 0.39
ATP4A P20648 1/20 0.38
ATP4B P51164 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
GAA P10253 1/20 0.38
CD38 P28907 2/20 0.37
KCNH2 Q12809 1/20 0.37
DRD2 P14416 1/20 0.37
DRD4 P21917 1/20 0.37
DRD3 P35462 1/20 0.37
ALDH1A1 P00352 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7617293 0.94 PARP1 (0.46) CYP3A4CYP2C9CYP2D6CYP1A2CYP2C19
SCHEMBL7611919 0.90 CYP3A4 (0.53) CYP3A4CYP2C9CYP2D6CYP1A2CYP2C19
SCHEMBL7612343 0.80 CYP3A4 (0.53) CYP3A4CYP2C9CYP2D6CYP1A2CYP2C19
SCHEMBL5901958 0.80 CYP3A4 (0.46) CYP3A4CYP2C9CYP2D6CYP1A2CYP2C19
SCHEMBL7613739 0.79 MEN1 (0.42) CYP3A4CYP2C9CYP2D6CYP1A2CYP2C19
SCHEMBL6028469 0.78 CYP3A4 (0.41) CYP3A4CYP2C9CYP2D6CYP1A2CYP2C19
SCHEMBL5788740 0.76 PARP1 (0.54) CYP2C9CYP2D6CYP1A2CYP2C19PARP1
SCHEMBL7610690 0.76 DRD2 (0.56) PARP1MEN1KMT2AGAACD38
SCHEMBL6029299 0.73 CYP3A4 (0.38) CYP3A4CYP2C9CYP2D6CYP1A2CYP2C19
SCHEMBL7617298 0.73 CYP3A4 (0.44) CYP3A4CYP2C9CYP2D6CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0906288-B1 NEW COMPOUNDS ASTRAZENECA AB (SE) 2002-11-06 EP claimed
US-6465505-B1 SUCH AS 4-(2,6-DIMETHYLBENZYLAMINO OR BENZYLOXY)-2-METHYL BENZIMIDAZOLE; INHIBITING EXOGENOUS OR ENDOGENOUS STIMULATED GASTRIC ACID SECRETION; PREVENTION AND TREATMENT OF GASTRO-INTESTINAL INFLAMMATORY DISEASES ASTRAZENECA AB (SE) 2002-10-15 US claimed
EP-0906288-A1 NEW COMPOUNDS Astra Aktiebolag (SE) 1999-04-07 EP claimed
WO-1997047603-A1 NEW COMPOUNDS ASTRA AKTIEBOLAG (SE) 1997-12-18 WO claimed
EP-0906288-B1 NEW COMPOUNDS ASTRAZENECA AB (SE) 2002-11-06 EP disclosed
US-6465505-B1 SUCH AS 4-(2,6-DIMETHYLBENZYLAMINO OR BENZYLOXY)-2-METHYL BENZIMIDAZOLE; INHIBITING EXOGENOUS OR ENDOGENOUS STIMULATED GASTRIC ACID SECRETION; PREVENTION AND TREATMENT OF GASTRO-INTESTINAL INFLAMMATORY DISEASES ASTRAZENECA AB (SE) 2002-10-15 US disclosed
EP-0906288-A1 NEW COMPOUNDS Astra Aktiebolag (SE) 1999-04-07 EP disclosed
WO-1997047603-A1 NEW COMPOUNDS ASTRA AKTIEBOLAG (SE) 1997-12-18 WO disclosed